Cancer-related fatigue and associated disability in post-treatment cancer survivors

Journal of Cancer Survivorship

Volumn 10, Issue 1, 2016, Pages 51-61

  Jones, Jennifer M ^a   Olson, Karin ^b   Catton, Pamela ^a   Catton, Charles N ^a   Fleshner, Neil E ^a   Krzyzanowska, Monika K ^a   McCready, David R ^a   Wong, Rebecca K S ^a   Jiang, Haiyan ^a   Howell, Doris ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cancer related fatigue; Disability; Post treatment survivorship

Indexed keywords

AGED; COHORT ANALYSIS; COMORBIDITY; COMPLICATION; DEPRESSION; DISABLED PERSON; FATIGUE; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; SURVIVOR;

AGED; COHORT STUDIES; COMORBIDITY; DEPRESSION; DISABLED PERSONS; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; SURVIVORS;

EID: 84953634860     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-015-0450-2     Document Type: Article

References (106)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers CD, Parkin D. Cancer incidence and mortality worldwide: IARC Cancer. GLOBO CAN 2008. 2010.
2. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. SEER cancer statistics review, 1975–2005. Bethesda: National Cancer Institute; 2007.
3. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations). Bethesda: National Cancer Institute; 2012.
4. Jemal A, Ward E, Thun M. Declining death rates reflect progress against cancer. PLoS ONE. 2010;5(3):e9584.
5. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94(10):2766–92.
6. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12(1):20–37. Epub 2007/01/18.
7. Temple L, Wang E, McLeod R. Preventive health care: follow-up after breast cancer. Can Med Assoc J. 1999;18(4):73–90.
8. Lethborg CE, Kissane D, Burns WI, Snyder R. "Cast adrift": The experience of completing treatment among women with early stage breast cancer. J Psychosoc Oncol. 2000;18(4):73–90.
9. Ristovski-Slijepcevic S. Environmental scan of cancer survivorship in Canada: conceptualization, practice and research. Vancouver, BC: BC Cancer Agency; 2008. http://www.partnershipagainstcancer.ca/wp-content/uploads/Survivorship_Svetlana_Ristovski-Slijepcevic.pdf
10. Klabunde CN, Ambs A, Keating NL, He Y, Doucette WR, Tisnado D, et al. The role of primary care physicians in cancer care. J Gen Intern Med. 2009;24(9):1029–36. Epub 2009/07/15.
11. Klabunde CN, Han PK, Earle CC, Smith T, Ayanian JZ, Lee R, et al. Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med. 2013;45(7):463–74.
12. Roorda C, Berendsen AJ, Groenhof F, van der Meer K, de Bock GH. Increased primary healthcare utilisation among women with a history of breast cancer. Support Care Cancer. 2013;21(4):941–9.
13. Heins MJ, Korevaar JC, Rijken PM, Schellevis FG. For which health problems do cancer survivors visit their general practitioner? Eur J Cancer. 2013;49(1):211–8.
14. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, et al. NCCN Practice guidelines for cancer-related fatigue. Oncology (Williston Park). 2008;14(11A):151–61.
15. Prue G, Rankin J, Allen J, Gracey J, Cramp F. Cancer-related fatigue: a critical appraisal. Eur J Cancer. 2006;42(7):846–63.
16. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16(5):1689–96.
17. Miaskowski C, Portenoy RK. Update on the assessment and management of cancer-related fatigue. Principles and Practice of Supportive Oncology Updates. 1998;1:1–10.
18. Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol. 1999;17(1):253–61.
19. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743–53.
20. Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, et al. Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer. 2000;8(3):215–22.
21. Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19(14):3385–91.
22. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. Eur J Cancer. 2002;38:27–43.
23. Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol. 2003;21(7):1249–54.
24. Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol. 2005;23(27):6613–22.
25. Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106(4):751–8.
26. Kim SH, Son BH, Hwang SY, Han W, Yang JH, Lee S, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage. 2008;35(6):644–55.
27. Weis J. Cancer-related fatigue: prevalence, assessment and treatment strategies. Expert Rev Pharmacoecon Outcomes Res. 2011;11(4):441–6.
28. Wang XS, Zhao F, Fisch MJ, O'Mara AM, Cella D, Mendoza TR, et al. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014;120(3):425–32. Epub 2014/01/18.
29. Servaes P, Gielissen MF, Verhagen S, Bleijenberg G. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psycho-Oncology. 2007;16(9):787–95.
30. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Development of fatigue in cancer survivors: a prospective follow-up study from diagnosis into the year after treatment. J Pain Symptom Manag. 2013;45(2):213–22. Epub 2012/08/29.
31. Storey DJ, Waters RA, Hibberd CJ, Rush RW, Cargill AT, Wall LR, et al. Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study. Ann Oncol: Off J Eur Soc Med Oncol / ESMO. 2007;18(11):1861–9.
32. Alexander S, Minton O, Andrews P, Stone P. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer. 2009;45(3):384–92.
33. Knobf MT. Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer. J Clin Oncol. 1986;4(5):678–84.
34. Richardson A. Fatigue in cancer patients: a review of the literature. Eur J Cancer Care. 1995;4(1):20–32.
35. Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol. 1997;34(3:Suppl 2):4–12.
36. Longman AJ, Braden CJ, Mishel MH. Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time. Oncol Nurs Forum. 1999;26(5):909–15.
37. Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol. 2000;11(8):971–5.
38. Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist. 2000;5(5):353–60.
39. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. JNCI Monogr. 2004;2004(32):40–50.
40. Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104(11 Suppl):2565–76.
41. McNeil C. No rest for fatigue researchers. J Natl Cancer Inst. 2008;100(16):1129–31.
42. Campos MP, Hassan BJ, Riechelmann R, Del Giglio A. Cancer-related fatigue: a practical review. Ann Oncol: Off J Eur Soc Med Oncol / ESMO. 2011;22(6):1273–9.
43. Loge JH, Abrahamsen AF, Ekeberg, Kaasa S. Fatigue and psychiatric morbidity among Hodgkin's disease survivors. J Pain Symptom Manag. 2000;19(2):91–9.
44. Knobel H, Havard LJ, Brit LM, Forfang K, Nome O, Kaasa S. Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol. 2001;19(13):3226–33.
45. Ellison LF, Wilkins K. Cancer prevalence in the Canadian population. Health Rep. 2009;20(1):7–19.
46. Van Belle S, Paridaens R, Evers G, Kerger J, Bron D, Foubert J, et al. Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer. 2005;13(4):246–54.
47. Dillman DA. Mail and telephone surveys: the total design method. New York: Wiley & Sons; 1978.
48. Dillman DA. Mail and Internet surveys—the tailored design method. New York: Wiley & Sons; 1999.
49. Dillman DA. Mail and Internet surveys: the tailored design method 2007 update with new Internet, visual, and mixed-mode guide. Hoboken: John Wiley & Sons, Inc; 2007.
50. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manag. 1997;13(2):63–74.
51. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.
52. Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manag. 2002;24(6):547–61.
53. Minton O, Stone P. How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature. Breast Cancer ResTreat. 2008;112(1):5–13.
54. Minton O, Stone P. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol. 2009;20(1):17–25.
55. Alexander S, Minton O, Stone PC. Evaluation of screening instruments for cancer-related fatigue syndrome in breast cancer survivors. J Clin Oncol. 2009;27(8):1197–201.
56. Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;88(11):815–23.
57. Federici S, Meloni F. WHODAS II: Disability self-evaluation in the ICF conceptual frame. In: Stone JH, Blouin M, editors. International encyclopedia of rehabilitation; 2010. http://cirrie.buffalo.edu/encyclopedia/en/article/299/.
58. Andrews G, Kemp A, Sunderland M, Von Korff M, Ustun TB. Normative data for the 12 item WHO Disability Assessment Schedule 2.0. PLoS ONE. 2009;4(12):e8343.
59. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A(9):1326–36.
60. Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol. 2005;58(6):595–602.
61. Groll DL, Heyland DK, Caeser M, Wright JG. Assessment of long-term physical function in acute respiratory distress syndrome (ARDS) patients: comparison of the Charlson Comorbidity Index and the Functional Comorbidity Index. Am J Phys Med Rehabil. 2006;85(7):574–81.
62. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
63. Eaton WW, Muntaner C, Smith C, Tien A, Ybarra M. Center for epidemiologic studies depression scale: review and revision (CESD and CESD-R) In: Maruish ME, editor. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, Vol. 3. Mahwah NJ: Lawrence Erlbaum Assoc Inc; 2004.
64. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto: Consulting Psychologists Press, Inc; 1983.
65. Little RJA. A test of missing completely at random for multivariate data with missing values. J Am Stat Assoc. 1988;83(404):1198–202.
66. Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94(2):528–38.
67. Krzywinski M, Altman N. Visualizing samples with box plots. Nat Methods. 2014;11(2):119–20.
68. Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M. It's not over when it's over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med. 2010;40(2):163–81.
69. Thong MS, Mols F, Wang XS, Lemmens VE, Smilde TJ, van de Poll-Franse LV. Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient reported outcomes following initial treatment and long term evaluation of survivorship registry. Eur J Cancer. 2013;49(8):1957–66.
70. Andrykowski MA, Curran SL, Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med. 1998;21(1):1–18.
71. Jacobsen PB, Donovan KA, Small BJ, Jim HS, Munster PN, Andrykowski MA. Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer. 2007;110(8):1851–9.
72. Üstün TB, Kostanjsek N, Chatterji S, Rehm J. Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva, Switzerland: World Health Organization; 2009.
73. Neefjes EC, van der Vorst MJ, Blauwhoff-Buskermolen S, Verheul HM. Aiming for a better understanding and management of cancer-related fatigue. Oncologist. 2013;18(10):1135–43.
74. Bower JE. Prevalence and causes of fatigue after cancer treatment: the next generation of research. J Clin Oncol. 2005;23(33):8280–2.
75. Jacobsen PB, Donovan KA, Weitzner MA. Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry. 2003;8(4):229–40.
76. Donovan KA, Jacobsen PB. Fatigue, depression, and insomnia: evidence for a symptom cluster in cancer. Semin Oncol Nurs. 2007;23(2):127–35.
77. Oh HS, Seo WS. Systematic review and meta-analysis of the correlates of cancer-related fatigue. Worldviews Evid Based Nurs. 2011;8(4):191–201.
78. Brown LF, Rand KL, Bigatti SM, Stewart JC, Theobald DE, Wu J, et al. Longitudinal relationships between fatigue and depression in cancer patients with depression and/or pain. Health Psychol. 2013;32(12):1199–208.
79. Goldstein D, Bennett B, Friedlander M, Davenport T, Hickie I, Lloyd A. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer. 2006;6:240.
80. Brown LF, Kroenke K. Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics. 2009;50(5):440–7.
81. Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 2011;29(26):3517–22.
82. Jacobsen PB, Stein K. Is fatigue a long-term side effect of breast cancer treatment? Cancer Control. 1999;6:256–63.
83. Olson K, Hayduk L, Thomas J. Comparing two approaches for studying symptom clusters: factor analysis and structural equation modeling. Support Care Cancer. 2014;22(1):153–61.
84. Jacobsen PB. Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;(32):93-7.
85. Smets EM, Garssen B, Cull A, de Haes JC. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer. 1996;73(2):241–5.
86. Stone P, Richards M, A'Hern R, Hardy J. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manag. 2001;22:1007–15.
87. Stone P, Hardy J, Huddart R, A'Hern R, Richards M. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer. 2000;36(9):1134–41.
88. Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PL, Flynn PJ, et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003;21(24):4635–41.
89. Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Griggs JJ, Matteson SE, et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2005;89(3):243–9. Epub 2005/03/09.
90. Howell D, Keller-Olaman S, Oliver TK, Hack T, Broadfield L, Biggs K, et al. A pan-Canadian practice guideline: screening, assessment and care of cancer-related fatigue in adults with cancer. Toronto: Canadian Partnership Against Cancer (Cancer Journey Advisory Group) Canadian Association of Psychosocial Oncology; 2011; Available from: http://capo.ca/Fatigue_Guideline.pdf.
91. Network NCC. Clinical practice guidelines in oncology: cancer related fatigue. Version 1. 2013. National Comprehensive Cancer Network; 2013; Available from: http://www.nccn.org.
92. Network NCC. Clinical practice guidelines in oncology. Survivorship (version 1.2013). 2013.
93. Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32(17):1840–50.
94. Reif K, de Vries U, Petermann F, Gorres S. A patient education program is effective in reducing cancer-related fatigue: a multi-centre randomised two-group waiting-list controlled intervention trial. Eur J Oncol Nurs: Off J Eur Oncol Nurs Soc. 2013;17(2):204–13.
95. Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull. 2008;134(5):700–41.
96. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev. 2009;1, CD006953.
97. Mitchell SA, Beck SL, Hood LE, Moore K, Tanner ER. Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs. 2007;11(1):99–113. Epub 2007/04/20.
98. Barsevick AM, Dudley W, Beck S, Sweeney C, Whitmer K, Nail L. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004;100(6):1302–10.
99. Kummer F, Catuogno S, Perseus JM, Bloch W, Baumann FT. Relationship between cancer-related fatigue and physical activity in inpatient cancer rehabilitation. Anticancer Res. 2013;33(8):3415–22.
100. Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2008;2, CD006145.
101. Puetz TW, Herring MP. Differential effects of exercise on cancer-related fatigue during and following treatment: a meta-analysis. Am J Prev Med. 2012;43(2):e1–24.
102. Graydon JE, Bubela N, Irvine D, Vincent L. Fatigue-reducing strategies used by patients receiving treatment for cancer. Cancer Nurs. 1995;18(1):23–8.
103. Richardson A, Ream EK. Self-care behaviours initiated by chemotherapy patients in response to fatigue. Int J Nurs Stud. 1997;34(1):35–43.
104. Finnegan-John J, Molassiotis A, Richardson A, Ream E. A systematic review of complementary and alternative medicine interventions for the management of cancer-related fatigue. Integr Cancer Ther. 2013;12(4):276–90.
105. Minton O, Stone P, Richardson A, Sharpe M, Hotopf M. Drug therapy for the management of cancer related fatigue. Cochrane Database Syst Rev. 2008;1, CD006704.
106. Minton O, Richardson A, Sharpe M, Hotopf M, Stone PC. Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manag. 2011;41(4):761–7.